Introduction {#vms389-sec-0001}
============

The excessive use of antimicrobials in food‐producing animals rearing has raised serious concerns about the selection and transfer of multi‐resistant zoonotic foodborne pathogens of bacterial origin to human populations (Wegener [2003](#vms389-bib-0049){ref-type="ref"}). In addition, the use of drugs without respect to withdrawal periods constitutes a threat to consumers with the persistence of residues in animal products (Salama *et al*. [2011](#vms389-bib-0046){ref-type="ref"}; Darwish *et al*. [2013](#vms389-bib-0019){ref-type="ref"}). Another concern is related to the contamination of water and environment with chemical residues. The persistence of antimicrobials in manure and the use of old litter in soil fertilization permits the leakage of drugs into wells and surface water (Phuong Hua *et al*. [2011](#vms389-bib-0043){ref-type="ref"}; Meyer *et al*. [2013](#vms389-bib-0034){ref-type="ref"}; Milic *et al*. [2013](#vms389-bib-0035){ref-type="ref"}; Awad *et al*. [2014](#vms389-bib-0006){ref-type="ref"}).

In order to limit these concerns, the World Health Organisation (WHO) in collaboration with the Food and Agriculture Organisation (FAO) and the Office International des Epizooties (OIE) recommend banning the use of antimicrobials as growth promoters and called for more controls for the therapeutic and prophylactic administration of antibacterial drugs to food animals (OIE, [2003](#vms389-bib-0052){ref-type="ref"}; Collignon *et al*. [2009](#vms389-bib-0017){ref-type="ref"}; Aidara‐Kane [2012](#vms389-bib-0002){ref-type="ref"}; WHO, [2014](#vms389-bib-0051){ref-type="ref"}).

In Morocco, the last 5 years have seen tremendous increase in poultry production. The total production of poultry meat jumped from 320 000 tons in 2006 to 610 000 tons in 2015 (Fisa, [2015](#vms389-bib-0021){ref-type="ref"}). The broiler industry is the principal provider of animal protein making up 54% of total consumed meat. The broiler industry in Morocco has more than 7000 approved broiler units. The characteristics of broiler growing permit the production of pullets at the weight of 2.2 kg, at a mean of 42 rearing days and a conversion rate around 1.9 (Barkok [2007](#vms389-bib-0007){ref-type="ref"}). However, the sector is poorly regulated due to the dominance of live market: 90% of broilers are sold live, with only 10% of broiler production processed in industrial slaughterhouses \[Fédération Interprofessionnelle du Secteur Avicole (FISA) [2015](#vms389-bib-0021){ref-type="ref"}\]. The Moroccan authorities adopted a law (49.99) in 2006 following the worldwide crisis of avian influenza in order to regulate the poultry sector (Loi 49--99; 2002). Under the remit of the 49.99 law, all poultry producers are obliged to keep documents concerning the rearing, health status and treatments of their flocks (ONSSA, [2015](#vms389-bib-0040){ref-type="ref"}).

Moroccan producers and veterinary practitioners involved in the broiler production are regular users of antimicrobials, and it is well known that the use of antimicrobials (either in therapeutic or preventative ways) has become a routine measure in order to ensure economic profitability for the broiler producers (Landers *et al*. [2012](#vms389-bib-0031){ref-type="ref"}). In addition, antibacterial growth promoters (AGPs) are still permitted in Morocco and are used under veterinary prescription regularly by feed manufacturers. These AGP include arsenicals, antibiotics like virginiamycin, bacitracin, oxytetracycline, tylosin and coccidiostats. However, previous studies have shown treatment failures coupled with reports of increased antimicrobial resistance (Filali *et al*. [1988](#vms389-bib-0023){ref-type="ref"}; Amara *et al*. [1995](#vms389-bib-0003){ref-type="ref"}).

In addition, although Moroccan authorities have had a surveillance programme for some antimicrobials used in poultry, such as chloramphenicol and gentamicin since 2001 (ONSSA, [2015](#vms389-bib-0040){ref-type="ref"}), they do not perform proficient monitoring for antimicrobial use and consumption in food animals compared to the DANMAP ([2016](#vms389-bib-0018){ref-type="ref"}) (Danish Programme for surveillance of antimicrobial consumption and resistance in bacteria from animals) and GERMAP ([2016](#vms389-bib-0026){ref-type="ref"}) (German programme for monitoring the consumption of antimicrobials and the extent of resistances against antimicrobials in human and veterinary medicine) programmes in Europe or the NAHMS ([2016](#vms389-bib-0037){ref-type="ref"}) (National Animal Health Monitoring System) in the United States. These programmes are responsible for the collection, analysis and publication of data on sales and consumption of antimicrobials in livestock and food animals \[Chauvin *et al*. [2008](#vms389-bib-0015){ref-type="ref"}; Merle *et al*. [2012](#vms389-bib-0033){ref-type="ref"}; Food and Drug Administration (FDA) [2015a](#vms389-bib-0024){ref-type="ref"},[b](#vms389-bib-0025){ref-type="ref"}\]. Furthermore, there were no reported studies concerning the use and consumption of antimicrobials in the broiler production in Morocco. Therefore, it is important to document the level of antimicrobial use in broilers given the fact that it is the major source of meat and that poultry sector is considered as the major destination of commercialized antimicrobials.

The purpose of this study is to report the quantification and patterns of use of antimicrobials in the Moroccan broiler sector based on the results of a survey conducted at the prescribers\' level, that is, the private veterinarians involved in the health management of broiler production.

Materials and methods {#vms389-sec-0002}
=====================

Survey design and sampling {#vms389-sec-0003}
--------------------------

In Morocco, there are approximately 35 major veterinary clinics involved in the health management of poultry units. Among these, 20 clinics have more than 80% of the activity for the health management of poultry. The remaining 15 clinics only count poultry activity at the level of 35--60% (Bennani [2016](#vms389-bib-0010){ref-type="ref"}). Broiler producers are obliged to have management contracts with the veterinary clinics involved in poultry disease activity according to the 49.99 Moroccan law (Loi 49--99; 2002) (ONSSA, [2015](#vms389-bib-0040){ref-type="ref"}). We selected 20 veterinary clinics in the main geographical areas of poultry production and randomly chose records for at least 250 000 broilers raised from different flocks to investigate antimicrobial use. Randomization was done by assigning numbers to broiler flocks and selecting the first ascending list of random numbers in Excel spreadsheet. Twenty veterinary clinics were contacted, 12 responded and 8 were not willing to participate. From the 12 responding clinics, two sets of data were discarded because one included turkey production and the other only provided data about two flocks. The final data included 280 broiler units ranging from 5000 to 105 700 birds per flock.

In order to assess the sampling power of our study, we took into account 80% desired power, 1.96 for statistical significance and 5% error margin for sample size determination. The statistical calculation provided a sample size requirement of 245 flocks. In the survey, we collected data from 280 flocks which exceed sample size requirements.

Data collection {#vms389-sec-0004}
---------------

The survey included data of over 250 000 broilers produced during a period of 2 years. The veterinarians were asked to give information concerning the prescription of antimicrobial treatments for the treatment of flocks; question about AGPs were not included in the survey. We sent the veterinary clinics a questionnaire in which they were asked to report all treatment records of the different flocks reared during the study period. The questionnaire also included indications for treatments, information about the flocks and other data such as susceptibility tests as they are not usually reported in the producers\' treatment records. The data about the broiler flocks included the following: total number of birds in the flock, season of rearing, age at treatment and reasons for treatments. The information about the prescription and delivery of antibacterials concerned the indication for treatments, presence of bacteriological analysis (isolation of pathogens and antimicrobial susceptibility tests), prescribed antimicrobial substances, concentration of active substances, posology, delivered amount of antibacterials and follow‐up after the treatment. The following indications for treatments were included in the questionnaire: prevention against omphalitis, prevention against chronic respiratory diseases (CRD) and treatments for omphalitis, enteritis, colibacillosis, coccidiosis, feet problems or arthritis.

Data analysis {#vms389-sec-0005}
-------------

The collected data were entered in an Excel spreadsheet (Microsoft Corporation, Redmond, Washington, USA) for further statistical analysis that include descriptive statistics \[mean, standard deviation (SD), maximum and minimum (max, min) observations\] for flocks and treatments, and ANOVA analysis. The volumes of antimicrobials administered were converted to mg of active substance per kg live weight. Calculations for the frequency of use as well as the consumed amount of the different active substances, the differences between seasons, the age of administration for the broiler flocks and the differences in the distribution of treatment causes were performed.

In order to assess the correctness of prescription, the following weight indicators were chosen: the defined daily dose (DDD) that is defined as the nationally determined average maintenance dose per day and per kg chicken of a specific drug (Chauvin *et al*. [2001](#vms389-bib-0014){ref-type="ref"}; Jensen *et al*. [2004](#vms389-bib-0029){ref-type="ref"}). For poultry, the DDD was estimated based on the dosages mentioned in the Moroccan Dictionary of Veterinary Drugs ([2015](#vms389-bib-0036){ref-type="ref"}) (<http://www.dmv-maroc.com/>) and on the drug\'s instruction leaflet. Live weights of chicken were taken from weight standards table of Ross breeds. The used daily dose (UDD) describes the amount of active substance actually administered to the animals in mg/kg (Grave *et al*. [2004](#vms389-bib-0027){ref-type="ref"}). The UDD was calculated by dividing the amount of antimicrobial compound administered (mg) by the number of broilers time the average weight at treatment to define a standard treated bird (Timmerman *et al*. [2006](#vms389-bib-0047){ref-type="ref"}). The UDD/DDD ratios were calculated as a way to assess the correctness of dosage. Ratios between 0.8 and 1.2 were considered as correct dosing. Values \<0.8 and \>1.2 were considered to be under‐dose and overdose, respectively (Timmerman *et al*. [2006](#vms389-bib-0047){ref-type="ref"}). The consumption of antimicrobials was calculated by dividing the total amount of used antibacterial in mg by the average weight at slaughter for all the surveyed flocks. The Animal Level of Exposure to Antibacterials (ALEA; which is an exposure data used in France since 1999) was calculated by dividing the treated live weight by the total live weight of surveyed flocks (Anses report on sales survey, [2015](#vms389-bib-0004){ref-type="ref"}).

Results {#vms389-sec-0006}
=======

The survey included 280 flocks containing 5 658 600 broilers chicks reared between January 2014 and December 2015. The mean size of the flocks was 25 720 with minimum size of 5000 and the maximum of 105 700 birds per flock.

Antimicrobial treatments {#vms389-sec-0007}
------------------------

A total of 484 antimicrobial treatments (for entire flocks) were recorded; 222 were administered during the first week of age, 14 in the second week, 64 in the third week and 92 treatments for both weeks 4 and 5.

The majority of flocks (92.5%) received at least one treatment; 31.67% were treated twice, 16.7% received three treatments and 5% were given four antimicrobial treatments. Only 21 flocks totalizing 314 000 broilers (7.5%) did not receive any antimicrobial treatments.

According to these data, the number of antimicrobial treatments ranged from 0 to 5 with each flock of broiler receiving a median of 1.73 (±SD 1.01) antimicrobial treatments during its production life. The ALEA was 94.45%.

Concerning susceptibility testing, 32% of antimicrobial treatments were given on the basis of bacteriological investigation and antimicrobial susceptibility tests, whereas 68% were given empirically. The susceptibility tests were essentially done on *Escherichia coli* through agar diffusion methods using antibacterial discs according to EUCAST guidelines (EUCAST, [2016](#vms389-bib-0020){ref-type="ref"}). The reported reasons for treatments are shown in Table [1](#vms389-tbl-0001){ref-type="table-wrap"}.

###### 

Distribution of antimicrobial use related to reasons for treatment at different ages

  Reasons for treatments                                        Number of treatments   \%
  ------------------------------------------------------------- ---------------------- -------
  Prophylaxis at 1 week[\*](#vms389-note-0001){ref-type="fn"}   206                    42.56
  Prophylaxis at 2 weeks[†](#vms389-note-0001){ref-type="fn"}   4                      0.83
  Prophylaxis at 3 weeks[†](#vms389-note-0001){ref-type="fn"}   15                     3.10
  Colisepticaemia                                               123                    25.41
  Non‐specified enteritis                                       82                     16.94
  CRD                                                           77                     15.91
  Omphalitis                                                    15                     3.10
  Unspecified                                                   9                      1.86

\*Prophylaxis at first week means using antimicrobials to prevent early chick mortality. †Prophylaxis at 2 and 3 weeks means using antimicrobials to prevent chronic respiratory diseases.

John Wiley & Sons, Ltd

The reasons for antibacterial treatments were for both preventative and therapeutic purposes. Prevention against omphalitis and early chick mortality was the reason for 42.56% of treatments. Prevention against respiratory diseases \[especially chronic respiratory disease (CRD) associated with mycoplasma\] accounted for 3.93%; 3.10% of treatments administered in week 3 and 0.83% at week 2. Concerning therapeutic treatments, colisepticaemia was considered as the first reason for treatment by 25.41%. Treatments against enteric disorders were the second most common reason (16.94%) for therapeutic treatments. CRD was the third most common indication at 15.91%.

It is worth noting that omphalitis was treated in 3.14% of cases despite the prior use of preventative treatments. Also, it was noted that some veterinarians reported more than one reason for antimicrobial treatment such as enteric disorders plus respiratory diseases and prevention against chick mortality plus omphalitis.

Concerning the effect of the seasons on the distribution of treatments, there were significant differences by ANOVA in the seasonal distribution of antimicrobial treatments, noting that the majority of broiler flocks were raised in houses with no climate control systems. Winter was the season when broiler flocks received most treatments; 143 treatments for 44 surveyed flocks with a significant statistical difference (*P* \< 0.01) compared to other seasons (Fig. [1](#vms389-fig-0001){ref-type="fig"}). In summer, there were 133 treatments for 73 surveyed flocks, but in autumn and spring, the recorded treatments were 99 and 113, respectively, for 60 and 64 reared flocks and no statistical differences were noted.

![Distribution of antimicrobial uses per flock during different seasons.](VMS3-4-80-g001){#vms389-fig-0001}

Consumption of antimicrobial components {#vms389-sec-0008}
---------------------------------------

The survey revealed that enrofloxacin was the most commonly used antimicrobial with 108.6 kg of active substance for treating 2 904 800 broilers. Colistin was second with 1 164 060 millions of IU of colistin sulphate used equivalent to 56.78 kg of active molecule distributed either by administration in drinking water for 2 305 000 birds or intramuscular injection for 1 100 000 broilers.

Table [2](#vms389-tbl-0002){ref-type="table-wrap"} summarizes the different antimicrobials used as found in the survey, as well as their final amounts in g per active substance and the total number of birds treated.

###### 

Use of the active antibacterials identified in the survey

  Antibacterial     Number of treatments[a](#vms389-note-0003){ref-type="fn"}   Consumed amount in kg of active substance   Number of birds treated[a](#vms389-note-0003){ref-type="fn"}   Consumption (mg/kg)
  ----------------- ----------------------------------------------------------- ------------------------------------------- -------------------------------------------------------------- --------------------------------------------
  Enrofloxacin      117                                                         108.6                                       2 904 800                                                      18.69
  Colistin          139                                                         56.78                                       3 405 000                                                      8.40
  Amoxicillin       31                                                          66.74                                       765 300                                                        43.60
  Sulphonamides     85                                                          64.38                                       1 739 200                                                      18.51
  Trimethoprim      85                                                          13.463                                      1 739 200                                                      3.87
  Florfenicol       46                                                          110.45                                      1 034 000                                                      53.41
  Oxytetracycline   49                                                          263.19                                      1 440 000                                                      127.27
  Lincomycin        13                                                          2.38                                        191 000                                                        0.83
  Spectinomycin     13                                                          4.77                                        191 000                                                        12.48
  Doxycycline       6                                                           20.50                                       137 000                                                        53.66
  Tylosin           4                                                           2.55                                        61 000                                                         9.31
  Erythromycin      2                                                           0.60                                        53 200                                                         4.92
  Fosfomycin        2                                                           3.00                                        50 000                                                         28.20
  Neomycin          6                                                           0.33                                        116 000                                                        3.25
  Total                                                                         717.72                                      5 658 600[a](#vms389-note-0003){ref-type="fn"}                 63.48[a](#vms389-note-0003){ref-type="fn"}

The number of treatments and the number of treated birds are higher than the total number of surveyed broilers because most flocks received more than one antibiotic treatment.

John Wiley & Sons, Ltd

The UDD and DDD were distributed differently according to the antibacterial used and the age of treatment. The distribution ranged between 4.25 for oxytetracycline and 0.68 for sulfadiazine--trimethoprim (Table [3](#vms389-tbl-0003){ref-type="table-wrap"}).

###### 

UDD/DDD ratios for the main antibacterials in the survey

  Antibacterial                                                 Number of treated broilers   Mean day at treatment (no.)   Total live weight (kg) at the treatment day   DDD (g)      UDD (g)       UDD/DDD ratio
  ------------------------------------------------------------- ---------------------------- ----------------------------- --------------------------------------------- ------------ ------------- ---------------
  Enrofloxacin                                                  2 208 340                    Day 2 (67) + Day 25 (16)      758 690                                       7586.9       16 270        2.14
  Combination of enrofloxacin + colistin                        739 000                      Day 1 (2) + Day 24 (32)       763 698                                       7636.98      30 280        3.96
  65 335 MIU                                                    252 800 MIU                  3.87                                                                                                   
  Colistin (oral)                                               1 538 000                    Day 2 (42) + Day 17 (52)      676 780                                       50 758 MIU   128 000 MIU   2.52
  Colistin (injection)                                          1 160 000                    Day 26                        1 485 120                                     74 256 MIU   86 218 MIU    1.16
  Florfenicol                                                   1 034 000                    Day 1 (2) + Day 23 (45)       1 113 034.5                                   28 030.94    27 100        0.97
  Amoxicillin                                                   585 400                      Day 27                        817 580                                       15 629.2     11 380        0.73
  Sulfadimethoxine + TMP[a](#vms389-note-0004){ref-type="fn"}   1 365 000                    Day 3 (63) + Day 23 (7)       326 995                                       79 445.28    67 353.75     0.85
  Sulfadiazine + TMP[a](#vms389-note-0004){ref-type="fn"}       314 300                      Day 4 (9) + Day 25 (5)        258 318                                       77 495.4     53 000        0.68
  Oxytetracycline                                               1 075 000                    Day 24                        1 307 600                                     13 076       55 541.67     4.25

TMP, trimethoprim.

John Wiley & Sons, Ltd

The total amount of antimicrobial drugs per kg of produced broiler meat in this survey was 717.72 kg of all active components for 11 317 200 kg equivalent of broiler at the age of slaughter, which was equivalent to 63.48 mg of active antimicrobial component per kg of produced broiler meat.

Discussion {#vms389-sec-0009}
==========

The methodology of the survey took its basis from the 2012 Terrestrial Animal Health Code issued by the OIE ([2014](#vms389-bib-0053){ref-type="ref"}). This manual describes the nature of data recovery from records concerning the total number of treated animals, their estimated live weight, the total amount of active ingredients of the used antimicrobials and other information such as the age of treatment, the duration and the season where the antimicrobial treatment occurred.

The survey focused on data related to antimicrobial prescriptions and delivery from private veterinary practices, that is, the prescribers, involved in the health care of broilers in Morocco. Indeed, veterinarians are considered to be the most reliable way to obtain precise information on the nature of prescriptions, dosage, number of treatment days, age of birds at the time of treatment and the amount of antimicrobials delivered \[Chauvin *et al*. [2001](#vms389-bib-0014){ref-type="ref"}; World Organisation For Animal Health (OIE) [2014](#vms389-bib-0053){ref-type="ref"}\]. According to Moroccan law on poultry production, veterinary practitioners supervising the broiler operations must keep records at the farm (ONSSA, [2015](#vms389-bib-0040){ref-type="ref"}) the prescriptions, the dosage and the delivery of antibacterials. These data are difficult to obtain from either broiler producers or the veterinary pharmaceutical industry.

The results of this survey showed that the antimicrobials are commonly administrated to broilers. Indeed, 93% of the investigated flocks received treatments lasting at least 3 days during the period of rearing. The reasons for this regular consumption are multiple: poor rearing practices, low‐quality inputs especially day old chicks and feed, veterinary\' practices and lack of efficient control by authorities responsible for the safety of food animal production.

First of all, the structure of the poultry industry makes it difficult for broiler producers to install environmentally controlled plants (Barkok [2007](#vms389-bib-0007){ref-type="ref"}). The costs of these buildings is still high in Morocco and do not allow a rapid return on investments for broiler producers. The shrinking profit margins registered during the past years could be an important factor. In addition, there are no subsidies or financial support provided for producers investing in controlled houses. Therefore, the broiler flocks are continually under the pressure of seasonal factors of cold and heat coupled with poor biosecurity measures. This situation frequently drives the use of antibacterial agents to treat flocks. In fact, the use of traditional housing systems may explain the observed statistical difference in the density of treatments between seasons. The increase in treatments during winter may be because of low temperatures and stocking density stress in the houses resulting in poor ventilation.

Poor ventilation and litter quality are major sources of distress to broilers. When they are associated with high density (that the majority of producers use to elevate the temperature in winter in the absence of environmentally controlled houses), they could predispose to respiratory and digestive problems that the producers then try to solve with antimicrobial treatments (Manning *et al*. [2007](#vms389-bib-0032){ref-type="ref"}).

Another important factor in Morocco is the spread and the high pressure of some viral pathogens such as infectious bronchitis virus (Fellahi *et al*. [2015](#vms389-bib-0022){ref-type="ref"}) and the contamination of parental flocks with *Mycoplasma synoviae* (Nassik *et al*. [2014](#vms389-bib-0038){ref-type="ref"}). The viral pathogens lead to more secondary *E. coli* infections which further increase the use of antimicrobial treatments (Barnes *et al*. [2003](#vms389-bib-0008){ref-type="ref"}).

The poor quality of day‐old chicks can be considered as the major factor for the use of antimicrobials in broilers. The high prevalence of omphalitis and yolk infections leads to a systematic approach of using antimicrobials in chicks during the first week of life. This might explain why 41% of flocks received prophylactic treatments in the first week of age. These findings are different from the Chinese study of Krishnasamy *et al*. ([2015](#vms389-bib-0030){ref-type="ref"}) which found that 75% of antimicrobial treatments in broilers are administered during the grower stage. However, similar results to ours are reported in the Vietnamese study of Carrique‐Mas *et al*. ([2015](#vms389-bib-0013){ref-type="ref"}) with 84% of antimicrobials use in meat‐type chicken for prophylactic purposes.

Poultry feed in Morocco is of variable quality and is believed to be a major cause of enteric disorders, thereby increasing the use and consumption of antimicrobials. Indeed, a study about antimicrobial resistance reported an increase in amoxicillin level of resistance correlated with enteric disorders (Rahmatallah *et al*. [2017](#vms389-bib-0045){ref-type="ref"}). Non‐specific enteritis and necrotic enteritis are treated in the first place by amoxicillin followed by oxytetracycline. Coccidiosis is treated by sulphonamides.

The veterinary practitioners responsible for broiler flocks\' health management can also be considered as actors in this consumption of antimicrobials. The findings of overdosing with antibacterials such as oxytetracycline (UDD/DDD ratio of 4.25) and enrofloxacin (ratio of 2.14) question the prescription practices of the veterinarians. This might suggest that the prescribers are contributing to the over‐usage of antimicrobials. Veterinarians should apply good prescription practices for antimicrobials by stressing the need for an accurate diagnosis, the appropriate choice of antimicrobials, the best dose prescription and the use of alternative such as probiotics, organic acids or phytotherapy (Passantino [2007](#vms389-bib-0041){ref-type="ref"}; Hume [2011](#vms389-bib-0028){ref-type="ref"}). They have to educate broiler producers that antimicrobials are only used in case of extreme necessity and have to restrain themselves from over‐using prophylactic treatments (Aidara‐Kane [2012](#vms389-bib-0002){ref-type="ref"}). They should also put more emphasis on the application of biosecurity measures and good practice in hygiene and rearing management (Clark *et al*. [2012](#vms389-bib-0016){ref-type="ref"}).

The survey revealed that the prescription of treatments was for both prophylactic and therapeutic purposes in equal measure. This indicates that rearing broilers in Morocco is subject to many disease challenges. Veterinarians explained the use of prophylactic treatments by early chick mortality caused by egg yolk infection and high prevalence of respiratory diseases at the beginning of the third week of age. For therapeutic administrations, the main reasons were for controlling CRD (77 treatments) often complicated with colibacillosis (123 cases), enteritis (88 treatments) and other unspecified diseases such as arthritis (7 cases).

Concerning the frequencies of antimicrobial use in this survey, the results show that the most commonly used antimicrobials were colistin (27.85% of treatments), enrofloxacin (23.44%), the association of trimethoprim--sulphonamide compounds (17.03%) and oxytetracycline (9.81%).

These results differ from those found by the ANSES (France) and NAHMS (USA) reports where oxytetracycline was the most used antimicrobial with 39.34% and 43% of total antimicrobial sales in France and in the United States, respectively (Bondt *et al*. [2013](#vms389-bib-0012){ref-type="ref"}; Anses, [2015](#vms389-bib-0004){ref-type="ref"}; FDA, [2015a](#vms389-bib-0024){ref-type="ref"},[b](#vms389-bib-0025){ref-type="ref"}). Colistin was used at the rate of 6.58% in France and 2% (among other antibacterials) in the United States. Enrofloxacin was used in 0.63% of treatments in France and \<1% in the United States (Anses, [2015](#vms389-bib-0004){ref-type="ref"}; FDA, [2015a](#vms389-bib-0024){ref-type="ref"},[b](#vms389-bib-0025){ref-type="ref"}).

However, the French and American data concerned all animal species and were based on pharmaceutical sales. Also, AGPs are still used in the United States, although prohibited in France. In addition, enrofloxacin use has been banned for poultry in the United States since 2005 (Nelson *et al*. [2007](#vms389-bib-0039){ref-type="ref"}; FDA, [2015b](#vms389-bib-0025){ref-type="ref"}, final decision of the commissioner). One reason for these differences relates to the fact that 45% of antimicrobials used in food‐producing animals were distributed in the feed as the route of administration (FDA, [2015a](#vms389-bib-0024){ref-type="ref"},[b](#vms389-bib-0025){ref-type="ref"}), with tetracycline as the major compound. Also, 50% of tested *E. coli* in broilers in France were susceptible to tetracycline treatments (Anses Resapath, [2015](#vms389-bib-0005){ref-type="ref"}), while more than 60% of *E. coli* tested in Morocco were resistant (Amara *et al*. [1995](#vms389-bib-0003){ref-type="ref"}). Furthermore, recent reports show resistance in more than 90% of tested strains. Reasons are related to the excessive use of tetracycline as an AGP and frequently sold over the counter which has probably permitted the selection of resistant Gram‐negative organisms, especially *E. coli* (Rahmatallah *et al*. [2013](#vms389-bib-0044){ref-type="ref"}, [2017](#vms389-bib-0045){ref-type="ref"}).

The UDD/DDD ratio is a method for assessing the correctness of antimicrobial dosing (Persoons *et al*. [2012](#vms389-bib-0042){ref-type="ref"}). In our survey, oxytetracycline was the most markedly overdosed drug with a UDD/DDD ratio of 4.25. Amoxicillin and trimethoprim--sulfadiazine were under‐dosed with ratios of 0.73 and 0.68, respectively. These results differ from the Belgian study of Persoons *et al*. ([2012](#vms389-bib-0042){ref-type="ref"}) who reported slight overdosing for amoxicillin and trimethoprim--sulphonamides with UDD/DDD ratio of 1.3 for both antimicrobials.

For oxytetracycline, the reasons of this overdosage seemed to be related to the prescribers\' emphasis on its usage based on mg per litre of drinking water rather than a posology based on animal body weight. Regarding the excess of water consumption in birds especially in case of enteric disorders or heat stress (Morocco is a country with a hot climate), the dosing of the drug could therefore be overestimated. Furthermore, the delivery of antimicrobials is affected by the physicochemical properties of the water supply, especially for powder formulations. Several studies have demonstrated the ability of tetracycline to bind strongly to divalent metals, especially calcium and magnesium (Werner *et al*. [2006](#vms389-bib-0050){ref-type="ref"}; Wammer *et al*. [2011](#vms389-bib-0048){ref-type="ref"}). The well waters in Morocco are generally basic and contain significant traces of minerals (Belghiti *et al*. [2014](#vms389-bib-0009){ref-type="ref"}) that impede the solubility of certain antibacterials, especially oxytetracycline which may mitigate the overdosing.

Of concern are the differences noted in UDD/DDD ratios related to the age at treatment. For example, colistin and enrofloxacin ratios ranged between 2.1 at the grower stage (17--28 days of age) to 12 at the starter age (generally the first week). The reasons for this difference were also related to the prescription dosage in mg per litre of drinking water which gave overdosage in comparison to prescription based on live body weight when broilers were small.

The amount of consumed antimicrobials in this survey was 63.48 mg per kg of produced broiler meat which might be considered a significant amount. Yet in France, 78.06 mg of antimicrobials per kg of poultry products was used (Anses, [2015](#vms389-bib-0004){ref-type="ref"}), and in the United States usage of antimicrobials was estimated at 145 mg/kg (van Boeckel *et al*. [2015](#vms389-bib-0011){ref-type="ref"}). A study of Chinese use of antimicrobials in food‐producing animals ranged the consumption between 301 and 796 mg/kg (Krishnasamy *et al*. [2015](#vms389-bib-0030){ref-type="ref"}). However, comparison with these results is limited due to differences in data collection and methodology. In this study, data were obtained from prescribers and concerned only antimicrobials used in therapy or prophylactic purposes for broilers and not AGPs. In France, the consumption does not include AGP which are banned, but was assessed for all poultry products including several avian and anatidae species (broilers, layers, turkeys, quails, ducks, pigeons and goose), and the ratio was calculated based on the sales records of pharmaceutical companies (Anses, [2015](#vms389-bib-0004){ref-type="ref"}). In the United States, both the consumption of AGPs (including coccidiostats and arsenicals) and therapeutic antimicrobials was based on sales records in order to give a total estimate of antimicrobial consumption (van Boeckel *et al*. [2015](#vms389-bib-0011){ref-type="ref"}). The Chinese study was based on assumptions and mathematical modelling using data on the total amount of antimicrobials (including AGP and coccidiostats) sold for food animals and an estimation on poultry production at the time of the study (Krishnasamy *et al*. [2015](#vms389-bib-0030){ref-type="ref"}).

Conclusion {#vms389-sec-0010}
==========

This study is the first attempt to monitor antimicrobial use and consumption in the Moroccan broiler production. It shows that antimicrobials are used frequently, and the amounts tend to approach those of developed countries. Many intervening players including producers, private veterinarians and sanitary authorities are identified in this survey as potential causes for this regular use. These stakeholders need to achieve a common sense approach to the importance of enhancing the quality of broiler production versus controlling measures for antimicrobial use and consumption. The national authority responsible for animal production and food animal products control should set‐up surveillance and monitoring systems for antimicrobial use and antibacterial resistance levels in food‐producing animals.
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